Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch School of Medicine, 2 Riccarton Avenue, Christchurch, 8011, New Zealand.
Orthopedic and Spinal Surgery Department, Kingdom Hospital, P.O. Box 84400, Riyadh, 11671, Saudi Arabia.
Spine Deform. 2021 Jul;9(4):1073-1076. doi: 10.1007/s43390-021-00315-5. Epub 2021 Mar 2.
To evaluate the pain and functional effect of the COVID-19 pandemic on patients with ASD reflected by their response to SRS-22, ODI, and SF-36 questionnaires.
Patients who had stable pain and functional outcome scores over the preceding 2 years were enrolled in a local prospectively collected adult spinal deformity (ASD) database. A reanalysis of their SRS22, ODI and SF-36 data 14 days into confinement were compared to their last pre-confinement scores.
89 patients were included in this study (average age 60.7 years, 91% female) with an average time from last FU until confinement of 9.6 months. The ODI total score worsened by 5 points post-confinement with no difference seen in personal care, walking and social life. In contrast, the SRS-22 score showed small improvements in function/activity and satisfaction, but no significant differences for the other domains. Similarly, the SF-36 showed small improvements in physical function, physical and emotional role, vitality and PCS.
The global COVID-19 pandemic and ensuing confinement had variable overall effects on ASD patients, without the expected marked worsening. In addition, this study illustrates that the SRS-22 questionnaire is less influenced by environmental and psychological factors than the ODI supporting its objectivity and accuracy in the evaluation of the QoL of ASD patients.
通过 SRS-22、ODI 和 SF-36 问卷评估 COVID-19 大流行对 ASD 患者的疼痛和功能影响。
纳入在过去 2 年内疼痛和功能评分稳定的患者,入组至当地前瞻性收集的成人脊柱畸形(ASD)数据库。在隔离的第 14 天分析他们的 SRS22、ODI 和 SF-36 数据,并与他们最后一次隔离前的评分进行比较。
本研究共纳入 89 例患者(平均年龄 60.7 岁,91%为女性),末次随访至隔离的平均时间为 9.6 个月。隔离后 ODI 总分恶化 5 分,但个人护理、行走和社会生活方面无差异。相比之下,SRS-22 评分在功能/活动和满意度方面略有改善,但其他领域无显著差异。同样,SF-36 在生理功能、生理和情感角色、活力和 MCS 方面也有较小的改善。
全球 COVID-19 大流行及其后续的隔离对 ASD 患者有不同的总体影响,没有预期的明显恶化。此外,本研究表明 SRS-22 问卷受环境和心理因素的影响小于 ODI,支持其在评估 ASD 患者生活质量方面的客观性和准确性。